Log in

Relevant bibliographies by topics / Biocybernetic diagnostics and therapy / Journal articles

To see the other types of publications on this topic, follow the link: Biocybernetic diagnostics and therapy.

Journal articles on the topic 'Biocybernetic diagnostics and therapy'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Biocybernetic diagnostics and therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Reinhard Fuhr, Dr. phil., Martina Gremmler-Fuhr, M.A., and Milan Sreckovic, Ph.D. "Diagnostics in Gestalt Therapy." Gestalt Review 4, no. 3 (2000): 237. http://dx.doi.org/10.5325/gestaltreview.4.3.0237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Maksimova, E. V., and I. L. Kliaritskaia. "Hepatic encephalopathy, diagnostics, differential diagnostics and therapy with ornithine." Consilium Medicum 20, no. 12 (2018): 110–16. http://dx.doi.org/10.26442/20751753.2018.12.000019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Witasek, A. "FX Mayr diagnostics and therapy." Focus on Alternative and Complementary Therapies 8, no. 4 (June 14, 2010): 556–57. http://dx.doi.org/10.1111/j.2042-7166.2003.tb04101.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Noakes, P., and P. Byrne. "Informatics – electronic diagnostics and therapy." Die Psychiatrie 07, no. 02 (April 2010): 100–106. http://dx.doi.org/10.1055/s-0038-1669594.

Full text

Abstract:

SummaryMental health professionals did not ask for it, but the proliferation of health informatics and the integration of connectivity into our daily lives will facilitate and improve mental health outcomes – provided change is clinician-driven. To date, no one informatics system achieved dominance and there is no consensus about how to proceed. Key systems’ components are identified. There are multiple technical, clinical, ethical and financial considerations that have delayed the routine use of these systems even in highly developed health services. Several interacting systems are discussed across general medical and mental health services. Informatics can assist with the diagnosis of some mental health conditions (anxiety, mood and substance misuse disorders), and a balance needs to be struck between excessive self-diagnoses and empowered patients. Allied systems, for example telemedicine, can assist clinicians in physical and many mental health disorders, but less so, severe enduring mental illness. Computerised therapies have a growing evidence base but may not suit every patient and all disorders. Once electronic databases are established across psychiatry, they will be used outside the clinical arena to pursue diverse research and economic agendae, with other uses as yet undefined. We conclude by speculating on possible future developments.

APA, Harvard, Vancouver, ISO, and other styles

5

Haberlová, Jana, Alžběta Slabá, Petra Hedvičáková, and Tereza Doušová. "Spinal muscular atrophy - diagnostics, therapy, research." Neurologie pro praxi 17, no. 6 (December 1, 2016): 349–53. http://dx.doi.org/10.36290/neu.2016.073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Novosad, Jakub, and Irena Krčmová. "Bronchial asthma diagnostics and therapy highlights." Interní medicína pro praxi 20, no. 1 (March 1, 2018): 14–18. http://dx.doi.org/10.36290/int.2018.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Polz-Dacewicz, Małgorzata. "Cytomegalovirus – epidemiology, diagnostics, therapy and prophylaxis." Forum Zakażeń 4, no. 1 (April 2, 2013): 36–40. http://dx.doi.org/10.15374/fz2013008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Shabalin, V. V., and Yu I. Grinshteyn. "Cardiac sarcoidosis: modern diagnostics and therapy." Russian Journal of Cardiology 25, no. 11 (December 5, 2020): 4052. http://dx.doi.org/10.15829/29/1560-4071-2020-4052.

Full text

Abstract:

Cardiac sarcoidosis (CS) is a potentially life-threatening granulomatous heart disease with unclear etiology and a suspected pathological immune response to an unidentified antigenic trigger in individuals with a genetic predisposition. CS often occurs as a part of systemic sarcoidosis, but in rare cases it can be isolated. The latter phenotype is especially difficult to diagnose, since it requires a differential diagnosis with a number of other myocardial diseases. Depending on the location and area, the clinical performance can vary from asymptomatic to severe cardiac manifestations — decompensated heart failure, malignant arrhythmias and conduction disorders, as well as sudden death. Methods for diagnosing CS are constantly being improved. In the presented review, the emphasis is on modern methods, diagnostic criteria, and approaches to the therapy of CS.

APA, Harvard, Vancouver, ISO, and other styles

9

Eremeeva, K. V. "Mycoses in otorhinolaryngology: diagnostics, prevention, therapy." Medical Council, no. 18 (January 1, 2016): 14–17. http://dx.doi.org/10.21518/2079-701x-2016-18-14-17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Laczi, Ferenc. "Etiology, diagnostics and therapy of hyponatremias." Orvosi Hetilap 149, no. 29 (July 1, 2008): 1347–54. http://dx.doi.org/10.1556/oh.2008.28409.

Full text

Abstract:

A tanulmány klinikusok számára foglalja össze a hyponatraemiák kóroktanát, diagnosztikáját és kezelését. A hyponatraemia a leggyakoribb elektrolit-rendellenesség. Az enyhe és mérsékelt fokú hyponatraemia a hospitalizált betegek 15–30%-ában, súlyosabb formája azok 1–4%-ában fordul elő. Patofiziológiai szempontból a hyponatraemiák két fő csoportja különböztethető meg: nem ozmotikus eredetű hypervasopressinaemiás hyponatraemiák (hypovolaemiás, hypervolaemiás, euvolaemiás) és nem hypervasopressinaemiás hyponatraemiák (pseudohyponatraemia, vízmérgezés, cerebrális sóvesztő szindróma). Az enyhe hyponatraemiás betegek sokszor tünetmentesek. A súlyos hyponatraemia az életet veszélyeztető központi idegrendszeri tüneteket okozhat. A hyponatraemiás állapotok kórismézése során figyelemmel vagyunk az extracelluláris folyadék térfogatára, a klinikai tünetekre, a hyponatraemia súlyosságára, kifejlődésének sebességére és tartamára. A hyponatraemia okainak felderítésekor az első feladat a nem hypervasopressinaemiás hyponatraemiák és a hypervasopressinaemiás hyponatraemiák elkülönítése a plazma ozmolalitásának, a vércukornak, a szérumlipidek és -fehérjék szintjének mérésével. A további differenciáldiagnosztikus ténykedést a vizelet ozmolalitásának, az extracelluláris folyadék térfogatának és a vizelet nátriumkoncentrációjának meghatározása segíti. Az euvolaemiás hyponatraemiák legfontosabb megjelenési formája a SIADH. A SIADH diagnózisát az egyéb kórismék kizárása biztosítja; itt kulcsadat, hogy a csökkent plazmaozmolalitáshoz (<275 mosmol/ttkg) viszonyítva a vizelet ozmolalitása (>100 mosmol/ttkg) aránytalanul nagy. Az akut (<48 óra), súlyos hyponatraemia (<120 mmol/l) intenzív terápiát igényel a normális ozmotikus viszonyok gyors helyreállításával. (A szérum nátriumemelkedésének sebessége óránként 1 mmol/l.) A krónikus (>48 óra), szimptómás hyponatraemia kezelése során a szérum nátriumszintjének gyors emelkedése demyelinisatiós szindrómát okozhat. (A szérum nátriumemelkedésének sebessége ne haladja meg az óránkénti 0,5 mmol/l-t!) A krónikus aszimptómás hyponatraemia (a hypovolaemia kivételével) kezelésében a hagyományos eljárásokat (folyadékbevitel-korlátozás, demeclocyclin, lítium, urea, furosemid + sóbevitel) a közeli jövőben a vazopresszinreceptor-antagonisták alkalmazása válthatja fel. A 2-es típusú vazopresszinreceptor-antagonista lixivaptan, tolvaptan és satavaptan, továbbá az 1A+2 típusú vazopresszinreceptor-antagonista conivaptan elektrolitvesztés nélkül növeli a vese vízkiválasztását és emeli a szérum nátriumszintjét.

APA, Harvard, Vancouver, ISO, and other styles

11

Freyer, T., and D. Riemann. "Diagnostics an Therapy of Sleep Disorders." ZFA - Zeitschrift für Allgemeinmedizin 81, no. 10 (October 2005): 447–61. http://dx.doi.org/10.1055/s-2005-872474.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Leong, Jiayu, Jye Yng Teo, Vinay K. Aakalu, Yi Yan Yang, and Hyunjoon Kong. "Engineering Polymersomes for Diagnostics and Therapy." Advanced Healthcare Materials 7, no. 8 (January 15, 2018): 1701276. http://dx.doi.org/10.1002/adhm.201701276.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Steiger, Christoph, Alex Abramson, Phillip Nadeau, Anantha P. Chandrakasan, Robert Langer, and Giovanni Traverso. "Ingestible electronics for diagnostics and therapy." Nature Reviews Materials 4, no. 2 (December 17, 2018): 83–98. http://dx.doi.org/10.1038/s41578-018-0070-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Pollert, E., P. Kaspar, K. Zaveta, V. Herynek, M. Burian, and P. Jendelova. "Magnetic Nanoparticles for Therapy and Diagnostics." IEEE Transactions on Magnetics 49, no. 1 (January 2013): 7–10. http://dx.doi.org/10.1109/tmag.2012.2220757.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Lestin-Bernstein, Franka, Marc Tietke, Lutz Briedigkeit, and Oliver Heese. "Diagnostics and antibiotic therapy for spondylodiscitis." Journal of Medical Microbiology 67, no. 6 (June 1, 2018): 757–68. http://dx.doi.org/10.1099/jmm.0.000703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Palmblad, Eva. "Diagnostics and ideology." Scandinavian Journal of Disability Research 2, no. 1 (January 2000): 58–82. http://dx.doi.org/10.1080/15017410009510752.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Shi, Leming. "Arrays, molecular diagnostics, personalized therapy and informatics." Expert Review of Molecular Diagnostics 1, no. 4 (November 2001): 363–65. http://dx.doi.org/10.1586/14737159.1.4.363.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Kissová, Jarmila. "Anemia in oncology patients - diagnostics and therapy." Onkologie 12, no. 6 (December 15, 2018): 278–82. http://dx.doi.org/10.36290/xon.2018.050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Latta, Jiří, and Jana Povová. "Celiac disease in elderly - diagnostics, comorbidity, therapy." Interní medicína pro praxi 18, no. 1 (February 1, 2016): 33–34. http://dx.doi.org/10.36290/int.2016.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kurushina, O. V., A. E. Barulin, and E. P. Chernovolenko. "Alcoholic polyneuropathy: ways of diagnostics and therapy." Medical Council, no. 1 (March 6, 2019): 58–63. http://dx.doi.org/10.21518/2079-701x-2019-1-58-63.

Full text

Abstract:

The article is devoted to the analysis of the pathogenetic mechanisms of the formation of alcoholic lesions of the peripheral nervous system. Various clinical forms of alcoholic polyneuropathy are considered, ways to diagnose using modern instrumental and laboratory methods are proposed. The authors analyze the main ways of forming a therapeutic strategy, consider groups of drugs used to treat alcoholic polyneuropathy. The data of own clinical experience of using the preparation of thioctic acid are given.

APA, Harvard, Vancouver, ISO, and other styles

21

Ożóg, Łukasz, Wojciech Domka, Dorota Bartusik-Aebisher, and David Aebisher. "FLUORESCENCE DIAGNOSTICS AND PHOTODYNAMIC THERAPY IN CANCER." Acta Poloniae Pharmaceutica - Drug Research 77, no. 4 (October 9, 2020): 517–40. http://dx.doi.org/10.32383/appdr/127258.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Danilov, An B. Danilov. "Fibromyalgia: principles of diagnostics and complex therapy." Therapy 7-8_2018 (December 25, 2018): 38–46. http://dx.doi.org/10.18565/therapy.2018.7-8.38-46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Rades, Nadine, Kai Licha, and Rainer Haag. "Dendritic Polyglycerol Sulfate for Therapy and Diagnostics." Polymers 10, no. 6 (May 29, 2018): 595. http://dx.doi.org/10.3390/polym10060595.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Banerjee, Diponkar. "Reinventing Diagnostics for Personalized Therapy in Oncology." Cancers 2, no. 2 (June 2, 2010): 1066–91. http://dx.doi.org/10.3390/cancers2021066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Laufs, U. "Stable coronary artery disease - diagnostics and therapy." DMW - Deutsche Medizinische Wochenschrift 131, no. 11 (2006): 556–62. http://dx.doi.org/10.1055/s-2006-933696.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Lin, Jimmy Cheng-Ho. "Protein Microarrays for Cancer Diagnostics and Therapy." Medical Principles and Practice 19, no. 4 (2010): 247–54. http://dx.doi.org/10.1159/000312709.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Driggers, Todd. "Respiratory Diseases, Diagnostics, and Therapy in Snakes." Veterinary Clinics of North America: Exotic Animal Practice 3, no. 2 (May 2000): 519–30. http://dx.doi.org/10.1016/s1094-9194(17)30086-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Erfurt-Berge, Cornelia, and Regina Renner. "Chronic wounds – Recommendations for diagnostics and therapy." Reviews in Vascular Medicine 3, no. 1 (March 2015): 5–9. http://dx.doi.org/10.1016/j.rvm.2015.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Steinberger, M., and A. Beyer. "Cancer pain: case report, diagnostics and therapy." DMW - Deutsche Medizinische Wochenschrift 130, no. 23 (June 2005): 1449–56. http://dx.doi.org/10.1055/s-2005-870837.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Weihe, W. "Multiple Sclerosis - Cause, Diagnostics, Process and Therapy." ZFA - Zeitschrift für Allgemeinmedizin 81, no. 5 (May 2005): 205–15. http://dx.doi.org/10.1055/s-2005-836472.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Matricardi, Paolo Maria, Stephanie Dramburg, Chrysanthi Skevaki, and Harald Renz. "“Molecular extracts” for allergy diagnostics and therapy." Pediatric Allergy and Immunology 30, no. 1 (January 29, 2019): 55–58. http://dx.doi.org/10.1111/pai.13001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Conde, João, João Rosa, João C. Lima, and Pedro V. Baptista. "Nanophotonics for Molecular Diagnostics and Therapy Applications." International Journal of Photoenergy 2012 (2012): 1–11. http://dx.doi.org/10.1155/2012/619530.

Full text

Abstract:

Light has always fascinated mankind and since the beginning of recorded history it has been both a subject of research and a tool for investigation of other phenomena. Today, with the advent of nanotechnology, the use of light has reached its own dimension where light-matter interactions take place at wavelength and subwavelength scales and where the physical/chemical nature of nanostructures controls the interactions. This is the field of nanophotonics which allows for the exploration and manipulation of light in and around nanostructures, single molecules, and molecular complexes. What is more is the use of nanophotonics in biomolecular interactions—nanobiophotonics—has prompt for a plethora of molecular diagnostics and therapeutics making use of the remarkable nanoscale properties. In this paper, we shall focus on the uses of nanobiophotonics for molecular diagnostics involving specific sequence characterization of nucleic acids and for gene delivery systems of relevance for therapy strategies. The use of nanobiophotonics for the combined diagnostics/therapeutics (theranostics) will also be addressed, with particular focus on those systems enabling the development of safer, more efficient, and specific platforms. Finally, the translation of nanophotonics for theranostics into the clinical setting will be discussed.

APA, Harvard, Vancouver, ISO, and other styles

33

Guedes, Gabriela, Shiqi Wang, Hélder A. Santos, and Filipa L. Sousa. "Polyoxometalate Composites in Cancer Therapy and Diagnostics." European Journal of Inorganic Chemistry 2020, no. 22 (April 30, 2020): 2121–32. http://dx.doi.org/10.1002/ejic.202000066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Trailovic, Dragisa, Ivana Trailovic, and Ljubica Spasojevic-Kosic. "Equine metabolic syndrome: Etiopathogenesis, diagnostics and therapy." Veterinarski glasnik 69, no. 3-4 (2015): 259–69. http://dx.doi.org/10.2298/vetgl1504259t.

Full text

Abstract:

Equine metabolic syndrome (EMS) is a term adopted in 2002 in aim to define the complex pathology involving obesity, insulin resistance and laminitis in horses and ponies. The EMS was terminologically derived upon similar condition in humans. The metabolic disturbance in equines is developed sequentially to the primary chronic overfeeding, i.e. intake of surplus food to individual needs combined with insufficient activity of animal. The syndrome has been reported more frequently in ponies than in other breeds although genetic background of EMS has not been confirmed. The characteristic symptoms include regional collection of adipose tissue under the skin often distributed regionally i.e. in crest (neck from pool to withers), behind the shoulders, at the dock of the tail and in prepuce in males or in the udder in mares; as well as impaired locomotion and/or lameness in all four limbs and cycling disturbance in mares.

APA, Harvard, Vancouver, ISO, and other styles

35

Albrecht, H., J. A. Radosevich, and M. Babich. "Fundamentals of antibody-related therapy and diagnostics." Drugs of Today 45, no. 3 (2009): 199. http://dx.doi.org/10.1358/dot.2009.45.3.1341343.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Vahlensieck, W., and N. Jaeger. "Diagnostics and Therapy of Germinal Testicular Tumors." Urologia Internationalis 40, no. 1 (1985): 48–59. http://dx.doi.org/10.1159/000281033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kaman, W. E., J. P. Hays, H. P. Endtz, and F. J. Bikker. "Bacterial proteases: targets for diagnostics and therapy." European Journal of Clinical Microbiology & Infectious Diseases 33, no. 7 (February 18, 2014): 1081–87. http://dx.doi.org/10.1007/s10096-014-2075-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Cummins, G. "Smart pills for gastrointestinal diagnostics and therapy." Advanced Drug Delivery Reviews 177 (October 2021): 113931. http://dx.doi.org/10.1016/j.addr.2021.113931.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Liu, Xue, Chao Liu, Gang Liu, Wenxin Luo, and Ningshao Xia. "COVID-19: Progress in diagnostics, therapy and vaccination." Theranostics 10, no. 17 (2020): 7821–35. http://dx.doi.org/10.7150/thno.47987.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Grattoni, A., D. Fine, A. Ziemys, J. Gill, E. Zabre, R. Goodall, and M. Ferrari. "Nanochannel Systems for Personalized Therapy and Laboratory Diagnostics." Current Pharmaceutical Biotechnology 11, no. 4 (June 1, 2010): 343–65. http://dx.doi.org/10.2174/138920110791233280.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Svistushkin, V. M., and E. V. Sinkov. "External otitis: from differential diagnostics to etiotropic therapy." Medical Council, no. 18 (January 1, 2016): 6–9. http://dx.doi.org/10.21518/2079-701x-2016-18-6-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Tuchin, Valery V. "Laser Light Scattering in Biomedical Diagnostics and Therapy." Journal of Laser Applications 5, no. 2 (October 1993): 43–60. http://dx.doi.org/10.2351/1.4745330.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Torshina, Irina E. "Onychomycosis and onychodystrophy: differential diagnostics and rational therapy." Consilium Medicum 22, no. 7 (2020): 49–53. http://dx.doi.org/10.26442/20751753.2020.7.200290.

Full text

Abstract:

В статье представлен обзор современных данных по этиологии, патогенезу и клиническим проявлениям онихомикозов и ониходистрофий. Систе-матизированные аналитические сведения, представленные в статье, позволяют практическому врачу последовательно, в соответствии с предла-гаемыми алгоритмами, проводить дифференциальную диагностику заболеваний ногтей и назначать адекватную терапию. Автором предложены варианты лечения онихомикозов и ониходистрофий, дальнейшего ухода за ногтевыми пластинками после завершения терапии. Умелое сочетание топических средств линии препаратов Микостоп®, Миколепт® и Клавио® характеризуется достоверной эффективностью в реабилитации больных с онихомикозами и ониходистрофиями различного генеза. Ключевые слова: онихомикозы, ониходистрофии, алгоритмы диагностики, принципы терапии. Для цитирования: Торшина И.Е. Онихомикоз и ониходистрофии: дифференциальная диагностика и рациональная терапия. Consilium Medicum. 2020; 22 (7): 49–53. DOI: 10.26442/20751753.2020.7.200290

APA, Harvard, Vancouver, ISO, and other styles

44

Raevskaya, A. I., M. A. Vitkovskaya, P. P. Shevchenko, and S. M. Karpov. "ALZHEIMER'S DISEASE:CLINIC, MODERN METHODS OF DIAGNOSTICS AND THERAPY." EurasianUnionScientists 7, no. 56 (2018): 61–65. http://dx.doi.org/10.31618/esu.2413-9335.2018.7.56.61-65.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Avramenko, I. U., and N. S. Kosmynina. "Pompe disease: diagnostics and contemporary approaches of therapy." Modern pediatrics. Ukraine, no. 5(109) (September 28, 2020): 39–44. http://dx.doi.org/10.15574/sp.2020.109.39.

Full text

Abstract:

The article presents a clinical case of a child with an infantile form of Pompe disease. At the age of 5 months, the girl became ill with acute bronchitis and the gentle systolic murmur over the surface of the heart detected by the district pediatrician during auscultation was the reason for referral to a cardiologist. Echocardiography diagnosed hypertrophic cardiomyopathy and the child was hospitalized for further examination. The mother did not complain. Given the slightly reduced muscle tone, elevated levels of transaminases and hypertrophic cardiomyopathy, and after consultation with a neurologist and geneticist, it was decided to conduct a genetic examination. A pathogenic variant of p.1447G> A (p.Gly483Arg) was detected in the GAA gene in a homozygous state and a clinical diagnosis was made: Pompe disease, infantile classical form. One month after diagnosis, pre-existing human recombinant α-glucosidase replacement therapy was initiated. During 18 months of treatment, the child's condition was satisfactory, no adverse side effects from enzyme replacement therapy were recorded, but lysosomal glycogenic load in the heart tissue was significantly reduced (according to echocardiography). Pompe disease is a rare genetic disease that is important to diagnose in a timely manner. Today, it is extremely important for doctors to understand the timeliness of referral to specialized centers for the necessary genetic scanning of children with suspected CP. Diagnosis of CP involves the detection of characteristic symptoms, confirmation of the diagnosis based on the detected low level of α-glucosidase in the patient's blood. The appointment of specific therapy for CP can stop the progression of the disease and significantly improve the quality and life expectancy of such patients. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of these Institutes. The informed consent of the patient was obtained for conducting the studies. No conflict of interest was declared by the authors. Key words: Pompe disease, diagnosis, treatment.

APA, Harvard, Vancouver, ISO, and other styles

46

Valihrach, Lukas, Peter Androvic, and Mikael Kubista. "Circulating miRNA analysis for cancer diagnostics and therapy." Molecular Aspects of Medicine 72 (April 2020): 100825. http://dx.doi.org/10.1016/j.mam.2019.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Scalfi-Happ, Claudia, Zhenxin Zhu, Susanna Graefe, Arno Wiehe, Anastasia Ryabova, Victor Loschenov, Rainer Wittig, and Rudolf W. Steiner. "Chlorin Nanoparticles for Tissue Diagnostics and Photodynamic Therapy." Photodiagnosis and Photodynamic Therapy 22 (June 2018): 106–14. http://dx.doi.org/10.1016/j.pdpdt.2018.03.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Hamza, A., K. Fischer, E. Koch, A. Wicht, M. Zacharias, H. Loertzer, and P. Fornara. "Diagnostics and Therapy of Lymphoceles After Kidney Transplantation." Transplantation Proceedings 38, no. 3 (April 2006): 701–6. http://dx.doi.org/10.1016/j.transproceed.2006.01.065.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Baptista, Pedro. "Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy." Current Cancer Therapy Reviews 5, no. 2 (May 1, 2009): 80–88. http://dx.doi.org/10.2174/157339409788166733.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Kalinina, N. M. "CHRONIC FATIGUE SYNDROME: APPROACHES TO DIAGNOSTICS AND THERAPY." Russian Journal of Infection and Immunity 1, no. 3 (June 30, 2014): 267. http://dx.doi.org/10.15789/2220-7619-2011-3-267-270.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!